April 1995 - The CenterWatch Monthly : Volume 2, Issue 2, April 1995
Wanted: MCOs That Do Clinical Research
Sponsors siting of trials with managed care organizations (MCOs) is increasing dramatically, particularly for later phase studies.
Some MCOs are resisting clinical research because of wariness that it is part of sponsors' efforts to market drugs.
MCOs involved in clinical research find it beneficial for patients, company prestige, and profits.
Pharmaco Acquires Chicago Center for Clinical Research
Large CRO calls purchase a "strategic" move designed to improve its skills in site management.
Deal stirs questions over whether a CRO's ownership of a center for clinical studies presents a conflict of interest.
Many see purchase as a sign that CROs are aggressively seeking to become "full service" providers to sponsors, able to both manage and conduct clinical trials.
High Flying Future HealthCare Crashes
Value of Future HealthCare's stock plummets over 80 percent after company reports substantial "irregularities" in unbilled revenues; company now appears to never have been profitable.
In late 1994, as company's stock soared in value, its executives and directors sold over 235,000 shares for more than $5 million.
A New Focus in Clinical Research: Marketing, Marketing, Marketing
New marketing ideas and initiatives for investigative sites
- Phase I and II Watch